BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8546852)

  • 21. Lewy body disease and dementia. A review.
    Kalra S; Bergeron C; Lang AE
    Arch Intern Med; 1996 Mar; 156(5):487-93. PubMed ID: 8604954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholinergic regulation of cortical development and plasticity. New twists to an old story.
    Hohmann CF; Berger-Sweeney J
    Perspect Dev Neurobiol; 1998; 5(4):401-25. PubMed ID: 10533528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consciousness and hallucinations in schizophrenia: the role of synapse regression.
    Bennett A O MR
    Aust N Z J Psychiatry; 2008 Nov; 42(11):915-31. PubMed ID: 18941956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E epsilon4 and catechol-O-methyltransferase alleles in autopsy-proven Parkinson's disease: relationship to dementia and hallucinations.
    Camicioli R; Rajput A; Rajput M; Reece C; Payami H; Hao C; Rajput A
    Mov Disord; 2005 Aug; 20(8):989-94. PubMed ID: 15852364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dreaming and hallucinations - continuity or discontinuity? Perspectives from dementia with Lewy bodies.
    Collerton D; Perry E
    Conscious Cogn; 2011 Dec; 20(4):1016-20. PubMed ID: 21531149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease.
    Sinforiani E; Zangaglia R; Manni R; Cristina S; Marchioni E; Nappi G; Mancini F; Pacchetti C
    Mov Disord; 2006 Apr; 21(4):462-6. PubMed ID: 16228998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined blockade of cholinergic receptors shifts the brain from stimulus encoding to memory consolidation.
    Rasch BH; Born J; Gais S
    J Cogn Neurosci; 2006 May; 18(5):793-802. PubMed ID: 16768378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of the basal ganglia in the occurrence of paradoxical sleep dreams (hypothetical mechanism)].
    Sil'kis IG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2006; 56(1):5-21. PubMed ID: 16583673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dementia with Lewy bodies].
    Arsland D
    Tidsskr Nor Laegeforen; 2002 Feb; 122(5):525-9. PubMed ID: 11961984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease.
    Pacchetti C; Manni R; Zangaglia R; Mancini F; Marchioni E; Tassorelli C; Terzaghi M; Ossola M; Martignoni E; Moglia A; Nappi G
    Mov Disord; 2005 Nov; 20(11):1439-48. PubMed ID: 16028215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of hippocampal region CA3 to consciousness and schizophrenic hallucinations.
    Behrendt RP
    Neurosci Biobehav Rev; 2010 Jul; 34(8):1121-36. PubMed ID: 20034516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinergic systems mediate action from movement to higher consciousness.
    Woolf NJ; Butcher LL
    Behav Brain Res; 2011 Aug; 221(2):488-98. PubMed ID: 20060422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug induced dementia--anti-parkinsonian drugs].
    Naito Y; Kuzuhara S
    Nihon Rinsho; 2004 Jan; 62 Suppl():470-4. PubMed ID: 15011408
    [No Abstract]   [Full Text] [Related]  

  • 35. Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia.
    Perry EK; Marshall E; Kerwin J; Smith CJ; Jabeen S; Cheng AV; Perry RH
    J Neurochem; 1990 Oct; 55(4):1454-6. PubMed ID: 1697897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What Is the Link Between Hallucinations, Dreams, and Hypnagogic-Hypnopompic Experiences?
    Waters F; Blom JD; Dang-Vu TT; Cheyne AJ; Alderson-Day B; Woodruff P; Collerton D
    Schizophr Bull; 2016 Sep; 42(5):1098-109. PubMed ID: 27358492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems.
    Lawrence AD; Sahakian BJ
    Neurochem Res; 1998 May; 23(5):787-94. PubMed ID: 9566619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interplay of cholinergic function, attention, and falls in Parkinson's disease.
    Yarnall A; Rochester L; Burn DJ
    Mov Disord; 2011 Dec; 26(14):2496-503. PubMed ID: 21898597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Imaging of the Cholinergic System in Parkinson's Disease.
    Bohnen NI; Kanel P; Müller MLTM
    Int Rev Neurobiol; 2018; 141():211-250. PubMed ID: 30314597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholinergic dysfunction in Parkinson's disease.
    Müller ML; Bohnen NI
    Curr Neurol Neurosci Rep; 2013 Sep; 13(9):377. PubMed ID: 23943367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.